33 studies found for:
" July 29, 2009":" August 28, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
|
||||
| 2 | Enrolling by invitation |
Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
|
||||
| 3 | Unknown † |
Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-Infection - A Positron Emission Tomography (PET) Study
|
||||
| 4 | Recruiting |
Statin Therapy to Improve Atherosclerosis in HIV Patients
|
||||
| 5 | Withdrawn |
Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts
|
||||
| 6 | Completed |
Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
|
||||
| 7 | Unknown † |
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
|
||||
| 8 | Active, not recruiting |
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
|
||||
| 9 | Completed |
Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
|
||||
| 10 | Unknown † |
Raltegravir Switch for Toxicity or Adverse Events
|
||||
| 11 | Unknown † |
Genotypic Resistant HIV Strains in Taiwan
|
||||
| 12 | Active, not recruiting |
Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults
|
||||
| 13 | Active, not recruiting |
Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection
|
||||
| 14 | Recruiting |
Examining Benefits of HAART Continuation in Postpartum Mothers
|
||||
| 15 | Completed |
Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men
|
||||
| 16 | Recruiting |
Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
|
||||
| 17 | Completed |
Molecular Biology of Anal Cancer in HIV-Positive Patients
|
||||
| 18 | Completed |
CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
|
||||
| 19 | Unknown † |
Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)
|
||||
| 20 | Completed |
A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
|
† Indicates status has not been verified in more than two years
